Nebenwirkungen · Beovu
Beovu 120 mg/ml solution for injection in pre-filled syringe Beovu 120 mg/ml solution for injection · Abschnitt 4.8 · PDF-Seite 8
HOS-142883 · Präparat HOS-098894
Adverse reactions (Table 1) are listed according to the MedDRA system organ class. Within each system organ class, the adverse reactions are ranked by frequency, with the most frequent reactions first. Frequency categories for each adverse reaction are based on the following convention: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1 000 to <1/100), rare (≥1/10 000 to <1/1 000), very rare (<1/10 000), not known (cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-07T09:21:00Z · SHA-256 624db2d5864c2b820fff12c81cbd70718ac9c28b30c76dd3a29bf25022593409 · Passage 856fc5053a6454c0cf1f7e68fe44d16fcb0d12dd782807e9fd822bd249d9d475 · Zeichen 1197–1772 im Abschnitt